Related Experiment Video
Updated: Jul 28, 2026

Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
Annual report of the Australian National Poliovirus Reference Laboratory, 2002
Bruce R Thorley1, Kerri Anne Brussen, Vicki Stambos
1Poliovirus Reference Laboratory, Carlton South, Victoria. bruce.thorley@mh.org.au
Abstract:
Acute flaccid paralysis is the main clinical manifestation of poliomyelitis. Faecal specimens from cases of acute flaccid paralysis in Australia are referred to the National Poliovirus Reference Laboratory for virus culture to determine if poliovirus is the causative agent. Isolations of poliovirus are tested to determine whether they have characteristics of the Sabin oral polio vaccine virus strains or wild type polioviruses. In 2002, a poliovirus type 3, which tested as Sabin vaccine-like, was isolated from an Australian patient with acute flaccid paralysis. A non-polio enterovirus, Echovirus type 18, was isolated from the faecal specimens of another case of acute flaccid paralysis. In the same period, the laboratory identified 35 Sabin-like polioviruses from 52 referred specimens and isolates from cases without acute flaccid paralysis. Australia is a member nation of the World Health Organization's Western Pacific region that was declared free of endemic wild poliovirus in October 2000. Poliomyelitis remains endemic in three of the WHO regions of the world and wild poliovirus may be re-introduced to Australia. While the number of polio-endemic countries has been reduced to seven, the total number of wild polioviruses identified increased in 2002 compared to 2001 due to a sharp rise in isolations of wild virus from Northern India. Until global eradication of poliomyelitis is achieved, it is essential that a high level of poliovirus vaccination coverage, and surveillance for cases of acute flaccid paralysis, be maintained in Australia.
Insights
In 2002, Australian laboratories detected Sabin-like poliovirus and other enteroviruses in patients with acute flaccid paralysis. Continued surveillance and high vaccination coverage are crucial for preventing poliovirus re-introduction.
Area of Science:
- Virology
- Public Health
- Epidemiology
Background:
- Acute flaccid paralysis (AFP) is the primary symptom of poliomyelitis.
- Australia has been declared free of endemic wild poliovirus since October 2000.
- Poliomyelitis remains endemic in three World Health Organization (WHO) regions, posing a re-introduction risk.
Purpose of the Study:
- To investigate poliovirus and enterovirus detections in Australian cases of acute flaccid paralysis in 2002.
- To assess the ongoing need for surveillance and vaccination in Australia.
- To monitor the global poliomyelitis eradication progress.
Main Methods:
- Faecal specimens from AFP cases were cultured for poliovirus at the National Poliovirus Reference Laboratory.
- Isolates were tested to differentiate between Sabin oral polio vaccine strains and wild-type polioviruses.
- Non-polio enteroviruses were also identified.
Main Results:
- A Sabin-like poliovirus type 3 was isolated from an Australian AFP patient.
- Echovirus type 18, a non-polio enterovirus, was identified in another AFP case.
- The laboratory identified 35 Sabin-like polioviruses from 52 specimens, including those from non-AFP cases.
Conclusions:
- Despite being polio-free, Australia faces a risk of wild poliovirus re-introduction.
- Maintaining high poliovirus vaccination coverage and AFP surveillance is essential.
- Global eradication efforts are ongoing, with increased wild poliovirus detections in some regions in 2002.

